Grant: Project Grant
McMaster University
$256,274.00
Personalized Medicine for Canadians with Hemophilia: a pragmatic evaluation of Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-hemo) tailored dosing
EF 2017-18
Résumé
Hemophilia is an inherited (genetic) disorder where those affected lack the ability to produce components of blood required for clotting. This inability to clot can lead to bleeding, often in joints, causing pain and disability. Hemophilia is treated by injecting the missing blood components (clotting factors) into the blood stream. Computerized advice on how and when to inject the clotting factors could prevent bleeding and minimize unnecessary use of these expensive clotting factors. This study tests the safety & effectiveness of one such computerized advice system.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
371230
Name
Iorio Alfonso
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Health Policy & Systems Management Research
Projecttitle
Personalized Medicine for Canadians with Hemophilia: a pragmatic evaluation of Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-hemo) tailored dosing
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$256,274
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Computerized Clinical Decision Support; Hemophilia; Implementation Research; Knowledge Translation; Personalized Medicine; Population Pharmacokinetics
Abstract
Hemophilia is an inherited (genetic) disorder where those affected lack the ability to produce components of blood required for clotting. This inability to clot can lead to bleeding, often in joints, causing pain and disability. Hemophilia is treated by injecting the missing blood components (clotting factors) into the blood stream. Computerized advice on how and when to inject the clotting factors could prevent bleeding and minimize unnecessary use of these expensive clotting factors. This study tests the safety & effectiveness of one such computerized advice system.
Competitiondate
201709
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Iorio, Alfonso; Edginton, Andrea; Lillicrap, David P; Poon, Man-Chiu
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $256,274~ $0~